35Pharma

35Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

35Pharma is a clinical-stage biopharmaceutical company specializing in TGF-beta superfamily therapeutics for the treatment of Cardiometabolic Disease and Obesity. 35Pharma leverages its scientific leadership in TGF-beta biology combined with superior protein engineering to discover innovative compounds that selectively and potently neutralize validated pathological TGF-beta ligands while sparing beneficial homeostatic ligands. We believe in connecting rigorous science with our innate sense of urgency to rapidly generate breakthrough therapies for patients in need of a better quality of life. Our beautiful R&D and office facilities are located in the heart of Montreal, Canada, where a diverse team of industry professionals work together to execute on our mission to serve patients in need. If our corporate culture and dedication to patients resonate with you, we invite you to join our team: https://35pharma.com/careers/

Company Details

Employees
50
Address
Facilities Are Located In The Heart Of Montreal
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Laval.
Looking for a particular 35Pharma employee's phone or email?

35pharma Questions

News

Hypertension Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Addpharma Inc., Alnylam Therapeutics, ORPHAI THERAPEUTICS, 35Pharma Inc - Barchart.com

Hypertension Pipeline 2025: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Addpharma Inc., Alnylam Therapeutics, ORPHAI THERAPEUTICS, 35Pharma Inc Barchart.com

35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity - Yahoo Finance

35Pharma Closes Series C Financing to Advance Clinical Pipeline of Activin Inhibitors for Pulmonary Hypertension, Cardiometabolic Disease and Obesity Yahoo Finance

Hypertension Pipeline Drugs Report 2025: Unlocking Future Growth with Breakthrough Therapies in Development - The Globe and Mail

Hypertension Pipeline Drugs Report 2025: Unlocking Future Growth with Breakthrough Therapies in Development The Globe and Mail

AI deals give Canada’s startups a big year-end boost - The Logic

AI deals give Canada’s startups a big year-end boost The Logic

5 Startups Looking to Compete in the Obesity Space - BioSpace

5 Startups Looking to Compete in the Obesity Space BioSpace

Top 35Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant